InvestorsHub Logo
Followers 156
Posts 8875
Boards Moderated 1
Alias Born 05/28/2005

Re: S-BEES-BUMBLEBEE post# 49882

Monday, 01/02/2023 10:29:30 AM

Monday, January 02, 2023 10:29:30 AM

Post# of 51857

Articles of Conversion 08/31/2022 File: 20222587973

FACTS are that this deal is in the works and has only been in the making since September 2022. Deals of this nature take time to structure and can sometimes take 6-12 months depending on the scale of the business in the RM.

The delay in updating OTCMarkets to full Pink Current is inconsequential compared to the complexity of the reverse merger. We can return to Pink Current in weeks by updating a few pieces if information.

SBES IS NOW SOLEIL PHARMA owned by Suren Arjjarapu an India businessman!

When the up-and-coming company has real value but is overlooked for investors and many RM stocks, a reverse merger can be more explosive than the SPACS Biotech we covered on this website that went from penny to dollars. Mr. Suren Ajjarapu is an entrepreneur with leadership experience, extensive executive management and corporate board experience. Mr. Ajjarapu is a skilled corporate strategist, fundraiser and marketer. His vision and expertise in business performance has driven remarkable enterprise growth in the Biofuels and Information Technology sectors. Offering a rare blend of creative and operational strengths, Mr. Ajjarapu has demonstrated the ability to expand or launch new businesses on a global basis while tackling cross-cultural, socio-economic and geo-political boundaries. Time to go to market.

I am sure that Suren and his team would like to have the RM complete and the stock back to PC as quickly as shareholders but the fact of the matter is that complex transactions take careful crafting and time to complete.



GLTA SBES Soleil Pharma in 2023!

Cheers, Red

Entity Name:SOUTH BEACH SPIRITS, INC. Entity Number: E0418662012-0
Entity Type: Domestic Corporation (78) Entity Status: Converted Out
Formation Date: 08/10/2012 NV Business ID: NV20121491473
Termination Date:Perpetual
Annual Report Due Date: 8/31/2022
Total Authorized Capital: $20,301,500